Deutsche Bank downgraded Tecan (TCHBF) to Hold from Buy with a price target of CHF 225, down from CHF 298. With 7%-8% of sales exposed to National Institutes of Health funding, Tecan appears particularly vulnerable to spending cuts, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCHBF:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue